Tyr-He-Leu-OH) in vitro, the main points of hydrolysis being ArgX-Argy, Prol"-Tyrl' and Tyr"-lle12 (McDermott et al., 1983; Checler et a/., 1983 Checler et a/., , 1986 ). This communication describes attempts to identify the peptidases involved in neurotensin inactivation in human brain.
Synaptosomes were prepared from human post-mortem brain ( 12 g of frontal cortex; post-mortem deiay 15 h) by the method of Dodd et al. (1981) . Crude synaptic membranes were prepared by lysis of the synaptosomes for 1 h at 4°C in 5 mM-Tris/HCI (pH 8) and pelleted by centrifugation (160 000 g, 15 rnin). The membranes were washed twice with 0.2 M-NaCI in 10 mM-Tris/HCI (pH 7.4) and twice with 10 mM-Tris/HCI (pH 7.4) at 4°C. Neurotensin (40 p~) was incubated with membranes (1.2 mg of protein/ml) in 10 mMTris/HCI (pH 7.4) at 37°C for 15-180 min. The reaction mixture was then acidified with an equal volume of 1% trifluoroacetic acid (TFA) and the degradation products analysed by reversed-phase h.p.1.c. (Nova-Pak C 18 cartridge; 2.1-49% acetonitrile gradient over 20 min containing 11 rnM-TF.4; 1 ml/min; U.V. monitoring at 214 nm). Products were identified by comparing their elution times with those of standards (McDermott et al., 1982 (McDermott et al., , 1983 . After 2 h incubation in the absence of inhibitors, the following were the major peptide degradation products and their molar ratios: neurotensin ( 1 -8), 100; neurotensin ( 1-1 O), 77.8; neurotensin ( 1 -1 1 ), 16.1. The lack of corresponding C-terminal neurotensin fragments is explained by their further rapid degradation to amino acids including tyrosine which was identified in the h.p.1.c. profile. The partial inhibition of neurotensin degradation by carboxyphenylethyl-Ala-AlaPhe-p-aminobenzoate (CPE-AAF-pAB; an inhibitor of endopeptidase 24.15; Chu & Orlowski, 1984) was mainly due to prevention of neurotensin (1-8) formation (Table l) , consistent with the inhibition of a membrane-bound variant of endopeptidase 24.15 (EC 3.4.24.15) which cleaves the ArgX-Argy bond. Thiorphan (Roques et al., 1980) , an inhibitor of endopeptidase 24.1 1 (EC 3.4.24.1 1; cleaving at Pro"'-Tyrl' and Tyr"-Ilel*), had only a small overall inhibitory effect; this was accompanied by the almost complete inhibition of neurotensin (1-1 1 ) formation but by an increase in neurotensin ( 1 -10) formation. Therefore a second enzyme (in addition to endopeptidase 24.1 1) capable of hydrolysing the Pro"'-Tyrl' bond must be present on human synaptic Abbreviations used: pClu, pyroglutamic acid; TFA, trifluoroacetic acid; CPE-AAF-pAB, carboxyphenylethyl-Ala-Ala-Phe-paminobenzoate. thiorphan membranes as previously reported for rat membranes (Checler et al., 1986) . Captopril, an inhibitor of angiotensinconverting enzyme (Ondetti et al., 1977) , had no overall effect on neurotensin degradation, but appeared to inhibit conversion of neurotensin (1-10) to neurotensin (1-8) ( Checler et a/., 1983). Dynorphin (1-13) was the most effective inhibitor; the pattern of product formation was consistent with inhibition of the endopeptidase 24.1 5-like enzyme (McDermott et al., 1986) and the Pro'"-Tyrll-cleaving peptidase, while leaving endopeptidase 24.1 1 unaffected. In order to further characterize these peptidases, human brain synaptic membranes were solubilized in 20 mM-Tris/ HCI (pH 7.5) containing Triton X-100 (1%, v/v) at 4°C for 45 min and the extract was applied to an anion-exchange column (TSK-DEAE-SPW, 7.5 cm x 0.75 cm), eluting with a linear gradient of NaCl(0-0.5 M; 30 min) in 20 mM-Tris/HCI (pH 7.5) at 0.7 ml/min. Fractions (0.5 ml) were collected and assayed for neurotensin-degrading activity, the products being identified by reversed-phase h.p.1.c. Two peaks of activity were identified. The major peak (at 0.19 M-NaCI) hydrolysed neurotensin to give the ( 1 -10)-and ( I 1 -1 3)-peptides (i.e. at ProJi'-TyrJ I ) and the activity was inhibited by 1 mM-1,IO-phenanthroline and 2 mM-EDTA. A second peak of activity (at 0.23 M-NaCI) hydrolysed neurotensin at ArgX-Arg' and corresponded to endopeptidase 24.15. The major peak of activity was subjected to size exclusion chromatography (TSK-G3000-SW, 60 cm x 0.75 cm) eluting with 0.1 M-Tris/acetic acid (pH 7.4). The neurotensindegrading activity had an elution volume of 13.9 ml (Kc," 0.301) corresponding to an M, of 180000, compared with 72 000 for the equivalent rat metalloendopeptidase (Checler eta[., 1986) .
In summary, human synaptic membranes appear to have three main neurotensin-degrading enzymes, all metalloendopeptidases as reported for rat synaptic membranes. It is not yet clear which is responsible for controlling neurotensin levels in vivo.
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High M, multicatalytic peptidases in human and rat brain Cytosolic high-molecular-mass ( > 500 kDa) proteases have been implicated in the extralysosomal degradation of proteins and they appear to be involved in the degradation of ubiquitin-protein conjugates in at least some cell types. In this study, two high-M, cytosolic proteases have been isolated and partially characterized from both post-mortem human and rat brain. These soluble enzymes all appear to have similar M , values but exhibit different elution characteristics on ion-exchange chromatography.
Human temporal cortex (25 g, 24 h post-mortem delay) was homogenized in 5 vol. of 0.05~-Tris/HC1 pH 7.34 buffer containing 1 mM-EDTA and 1 mwdithiothreitol, the homogenate was centrifuged (27000 g for 15 min at 4°C) and the supernatant applied to a DE52 anion-exchange column (28 cm x 2.5 cm). A linear 200 ml Tris/HCl gradient (0.05-0.4 M ) was applied, the fractions collected ( 3 ml) and assayed for enzyme activity. This was done by incubating an aliquot (15 p l ) with each of two fluorogenic substrates Z-Gly-Gly-Arg-NMec (R) and glutaryl-Gly-Gly-Phe-NMec ( F 125 nM, pH 7.34, 1 h at 37°C total volume 300 pl). After adding ethanol (600 pl), the fluorescence of the liberated NMec was measured (excitation 380 nm; emission 440 nm). Two peaks of activity (I and 11) were identified (Fig. l a ) which were applied to a high-performance ion-exchange column (TSK-DEAE SPW, 7.5 mm x 75 mm) eluting with a 30 min linear gradient of Tris/HCl (pH 7.34; 0.05-0.4 M). Flow rate was 1 ml/min and 1 min fractions were collected. Peak I eluted at 0.27 M-and peak I1 at 0.3 M-Tris/HCI. However, subsequent chromatography of these fractions on a high-performance gel exclusion column (TSK G4000SW, 7.5 mm x 600 mm) indicated that both peptidase fractions had a molecular mass of 630 kDa (Fig. 1 h) . Rat brain (38 g) was extracted and subjected to anion-exchange chromatography as above. In addition to peaks I and 11, an additional peptidase peak was identified which only hydrolysed substrate R. Peaks I and I1 from rat brain were subjected to size exclusion chromatography and were found to have a molecular mass of 690 kDa.
Both human enzymes (peaks I and 11) hydrolysed substrates R and F at pH 7.4; their activity against substrate R increased around 2.5-fold at pH 10. No increase in activity was observed in the presence of 2 mM-ATP. The effect of various inhibitors on the activity of the major enzyme (peak I ) against substrates R (at pH 10) and F (at pH 7.4) was as follows (relative activity in parentheses, control = 100):
Abbreviation used: NMec. methylcoumarylamide. 
